CAPTRUST Financial Advisors’s Esperion Therapeutics ESPR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-10,050
| Closed | -$30.1K | – | 2311 |
|
|
2023
Q4 | $30.1K | Buy |
+10,050
| New | +$30.1K | ﹤0.01% | 2610 |
|
|
2023
Q3 | – | Sell |
-10,102
| Closed | -$14K | – | 2595 |
|
|
2023
Q2 | $14K | Buy |
+10,102
| New | +$14K | ﹤0.01% | 2473 |
|
|
2022
Q3 | – | Sell |
-2,312
| Closed | -$15K | – | 2666 |
|
|
2022
Q2 | $15K | Buy |
2,312
+2,128
| +1,157% | +$13.8K | ﹤0.01% | 3532 |
|
|
2022
Q1 | $1K | Buy |
184
+84
| +84% | +$457 | ﹤0.01% | 4684 |
|
|
2021
Q4 | $0 | Sell |
100
-450
| -82% | – | ﹤0.01% | 4807 |
|
|
2021
Q3 | $7K | Buy |
550
+382
| +227% | +$4.86K | ﹤0.01% | 3800 |
|
|
2021
Q2 | $4K | Buy |
168
+9
| +6% | +$214 | ﹤0.01% | 3943 |
|
|
2021
Q1 | $4K | Sell |
159
-291
| -65% | -$7.32K | ﹤0.01% | 3801 |
|
|
2020
Q4 | $12K | Hold |
450
| – | – | ﹤0.01% | 2479 |
|
|
2020
Q3 | $16K | Sell |
450
-100
| -18% | -$3.56K | ﹤0.01% | 2073 |
|
|
2020
Q2 | $28K | Buy |
+550
| New | +$28K | ﹤0.01% | 1817 |
|